145 related articles for article (PubMed ID: 15457300)
1. Gastrointestinal stromal tumours: etiology, pathology and clinical management.
Blackstein ME; Dubé P; Fletcher JA; Keller OR; Knowling M; Létourneau R; Morris D; Riddell R; Rorke S; Swallow CJ;
Can J Gastroenterol; 2004 Sep; 18 Suppl B():3B-8B. PubMed ID: 15457300
[TBL] [Abstract][Full Text] [Related]
2. Imatinib resistance in gastrointestinal stromal tumors.
Chen LL; Sabripour M; Andtbacka RH; Patel SR; Feig BW; Macapinlac HA; Choi H; Wu EF; Frazier ML; Benjamin RS
Curr Oncol Rep; 2005 Jul; 7(4):293-9. PubMed ID: 15946589
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with sunitinib in a young patient with metastatic gastrointestinal stromal tumor after failure on adjuvant imatinib.
Kapoor R; Khosla D; Kumar P; Kumar N; Bera A
J Cancer Res Ther; 2011; 7(4):491-3. PubMed ID: 22269418
[No Abstract] [Full Text] [Related]
4. [Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].
Zheng S; Jia J; Pan YL; Tao DY; Lu HS
Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):42-3. PubMed ID: 23611272
[No Abstract] [Full Text] [Related]
5. [Chemotherapy and target-therapy of gastrointestinal tumors call for development of pathology].
Shen L
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):438-9. PubMed ID: 17845753
[No Abstract] [Full Text] [Related]
6. Gastrointestinal stromal tumours (GISTs): case report and review of the literature.
Al-Amri AM; Shawarbi MA; El-Hassan AY; Al-Johi KS
Gulf J Oncolog; 2011 Jan; (9):57-60. PubMed ID: 21177210
[TBL] [Abstract][Full Text] [Related]
7. CT scan is not everything in the evaluation of a patient with gastrointestinal tumors (GIST) under imatinib therapy.
Wang CM; Fu H; Zhao GF; Wang J; Shi YQ
Pathol Oncol Res; 2012 Oct; 18(4):1095-7. PubMed ID: 21927980
[No Abstract] [Full Text] [Related]
8. Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.
Caram MV; Schuetze SM
J Surg Oncol; 2011 Dec; 104(8):888-95. PubMed ID: 22069173
[TBL] [Abstract][Full Text] [Related]
9. Evaluating new therapies in gastrointestinal stromal tumor using in vivo molecular optical imaging.
Hensley H; Devarajan K; Johnson JR; Piwnica-Worms D; Godwin AK; von Mehren M; Rink L
Cancer Biol Ther; 2014 Jul; 15(7):911-8. PubMed ID: 24755645
[TBL] [Abstract][Full Text] [Related]
10. Role of imatinib mesylate (Gleevec/Glivec) in gastrointestinal stromal tumors.
de Jong FA; Verweij J
Expert Rev Anticancer Ther; 2003 Dec; 3(6):757-66. PubMed ID: 14686698
[TBL] [Abstract][Full Text] [Related]
11. Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China.
Du CY; Zhou Y; Song C; Wang YP; Jie ZG; He YL; Liang XB; Cao H; Yan ZS; Shi YQ
Eur J Cancer; 2014 Jul; 50(10):1772-1778. PubMed ID: 24768330
[TBL] [Abstract][Full Text] [Related]
12. Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors.
De Giorgi U
Future Oncol; 2013 Nov; 9(11):1675-7. PubMed ID: 23862700
[No Abstract] [Full Text] [Related]
13. [Consensus on the medical treatment of gastrointestinal stromal tumors].
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):875-7. PubMed ID: 18396652
[No Abstract] [Full Text] [Related]
14. [Gastrointestinal stromal tumor (GIST)--tyrosine kinase inhibitors].
Nishida T; Yoshidome K; Tori M
Nihon Rinsho; 2012 Nov; 70 Suppl 8():452-6. PubMed ID: 23513883
[No Abstract] [Full Text] [Related]
15. Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.
Hsu CC; Wu CE; Chen JS; Tseng JH; Chiang KC; Liu YY; Tsai CY; Cheng CT; Chen TW; Jan YY; Yeh TS; Chen YY; Yeh CN
Anticancer Res; 2014 Sep; 34(9):5029-36. PubMed ID: 25202087
[TBL] [Abstract][Full Text] [Related]
16. Sunitinib for imatinib-resistant GIST.
Joensuu H
Lancet; 2006 Oct; 368(9544):1303-4. PubMed ID: 17046443
[No Abstract] [Full Text] [Related]
17. Complete pathological response in advanced extra-gastrointestinal stromal tumor after imatinib mesylate therapy: a case report.
Rediti M; Pellegrini E; Molinara E; Cerullo C; Fonte C; Lunghi A; Iori A; Neri B
Anticancer Res; 2014 Feb; 34(2):905-7. PubMed ID: 24511030
[TBL] [Abstract][Full Text] [Related]
18. Facial hyperpigmentation during imatinib therapy for gastrointestinal stromal tumor.
Hamza I; Gaies E; Kastalli S; Daghfous R; El Aidli S
Therapie; 2014; 69(3):245-7. PubMed ID: 24934821
[TBL] [Abstract][Full Text] [Related]
19. Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case report.
Bongiovanni A; Ricci M; Riva N; Calpona S; Oboldi D; Pieri F; Cavaliere D; Mercatali L; Liverani C; La Manna F; De Vita A; Foca F; Gunelli E; Amadori D; Ibrahim T
Future Oncol; 2014 Dec; 10(15):2423-7. PubMed ID: 25525851
[TBL] [Abstract][Full Text] [Related]
20. Imatinib mesylate.
Waller CF
Recent Results Cancer Res; 2010; 184():3-20. PubMed ID: 20072827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]